Join us for the First Annual Boston Society Medical Symposium on Acute Myeloid Leukemia (AML)
March 15, 2018

Broad Institute of MIT and Harvard 
415 Main Street 
Cambridge, MA 02142


Plenary Speaker


Gwen Nichols, MD, Chief Medical Officer, The Leuklemia & Lymphoma Society

Can AML Precision Science Become AML Precision Clinical Reality?



Invited Speakers 


Naval G. Daver, MD, Associate Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Immune Checkpoint and Vaccine Approaches in AML



Peter Marks, MD, PhD, Director, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration

FDA Work to Expedite the Development of Products to Address Serious and Life-Threatening Conditions


Daniel J. DeAngelo, MD, Director of Clinical and Translational Research, Adult Leukemia, Institute Physician, Associate Professor of Medicine, Harvard Medical School 

Current Standard of Care Guidelines


Bikash Verma, MD, DVM, Head, Clinical Development & Medical Affairs, Celyad

Novel CAR-T Therapy for AML 



John F. DiPersio, MD, PhD, Virginia E and Samuel J Golman Professor, Chief, Division of Oncology, Deputy Director, Siteman Cancer Center, Washington University School of Medicine

Novel Targeting of AML and T-ALL


Patrick Zweidler-McKay, MD, PhD, Medical Director for Hematologic Malignancies, ImmunoGen

ADCs in AML: GO and Beyond


Terry J. Fry, MD, Investigator, Pediatric Oncology Branch, Head, Hematologic Malignancies Section, Center for Cancer Research, National Cancer Institute

Immunotherapeutic Approaches for AML


Yi-Bin Albert Chen, MD, Program Director, Blood & Marrow Transplant (BMT) Program at the MGH Cancer Center

AML after Transplant: Are We Becoming High Maintenance?


Coleman Lindsley, MD, PhD, Assistant Professor, Harvard Medical School, Instructor, Medical Oncology, Dana-Farber Cancer Institute

genomics of myeloid malignancies -Title TBA



AML 2018 Sessions 

Session I:  The Current Landscape

Session II:  State of the Art Research and Treatment Options

Session III:  On the Horizon





 Join our Linkedin Group:


Session I:  The Current Landscape

Session II:  State of the Art Research and Treatment Options

Session III:  On the Horizon


Click here to register for the AML 2018 conference online.

AML 2018 will take place

March 15, 2018

Broad Institute

Cambridge, MA


The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3


Sign Up Today!

Privacy Policy